NCT05657821

Brief Summary

The goal of this to measure the effect of supplementation of Yellow Pumpkin Seed Extract Capsules in pregnant women on hemoglobin levels and nutritional status of pregnant women. The main question\[s\] it aims to answer are:

  • is there a difference in changes in nutritional status (increase in body weight and MUAC) in pregnant women who receive supplementation of Pumpkin Seed Extract Capsules and iron tablets
  • is there a difference in changes in hemoglobin levels in pregnant women who receive supplementation of Pumpkin Seed Extract Capsules and iron tablets. The research sample was divided into two groups, namely the intervention group and the control group. In the intervention group, pregnant women received pumpkin seed extract capsules for 12 weeks, while the control group received iron tablets for 12 weeks as well. Measurements of nutritional status (including measurements of body weight and Mid Upper Arm Circumference/MUAC) were carried out before and after the intervention and were monitored every month until 12 weeks when the intervention was carried out. As for measuring blood hemoglobin levels, it was taken before the intervention and after the intervention for 12 weeks

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Oct 2022

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 25, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 11, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 20, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 25, 2023

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 25, 2023

Completed
Last Updated

December 20, 2022

Status Verified

December 1, 2022

Enrollment Period

3 months

First QC Date

December 11, 2022

Last Update Submit

December 11, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Nutritional status

    measurements of body weight and Mid Upper Arm Circumference/MUAC) were carried out before and after the intervention and were monitored every month until 12 weeks when the intervention was carried out

    12 weeks

  • hemoglobin levels

    Hemoglobin level in the blood is measured by taking blood from the fingertip. Then measured using the digital strip method.

    12 weeks

Study Arms (2)

pumpkin seed extract capsules

EXPERIMENTAL

. In the intervention group, pregnant women received pumpkin seed extract capsules for 12 weeks

Dietary Supplement: Pumpkin seeds extract capsules

Iron tablets

PLACEBO COMPARATOR

the control group received iron tablets for 12 weeks

Dietary Supplement: Pumpkin seeds extract capsules

Interventions

the intervention group was given pumpkin seed capsules for 12 weeks, and the intervention group was given iron tablets for 12 weeks

Iron tabletspumpkin seed extract capsules

Eligibility Criteria

Age17 Years - 39 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnant woman
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • in the one or second trimester of pregnancy;
  • having no complications;
  • willing to participate in this study;
  • domiciled in the stunting locus village Bone regency .

You may not qualify if:

  • Pregnant women with complications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stunting Locus Village

Bone, South Sulawesi, 90000, Indonesia

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Indonesia Timur University

Study Record Dates

First Submitted

December 11, 2022

First Posted

December 20, 2022

Study Start

October 25, 2022

Primary Completion

January 25, 2023

Study Completion

August 25, 2023

Last Updated

December 20, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will share

IPD will be shared with other researchers when study is done

Shared Documents
STUDY PROTOCOL
Time Frame
when the study is done

Locations